C4 Therapeutics Inc (CCCC)
Healthcare
Biotechnology
3.50 $
+0.6%
vs. previous close
Closing price · As of: 3. Aug 2026
C4 Therapeutics Inc (CCCC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -99 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -17 | 56 | -67 | -87 | -106 | -107 | -65 | -99 | |
| 1.3 | 1.6 | 1.6 | 1.5 | 1.7 | 1.9 | 1.8 | 2.0 | |
| 0.6 | 1.6 | 3.4 | 22 | 30 | 27 | 30 | 19 | |
| 0.7 | 2.0 | 10 | 22 | 30 | – | – | – | |
| -5.6 | 85 | -13 | -30 | -17 | -6.9 | 7.6 | -29 | |
| 2.7 | 1.3 | 0.7 | 1.3 | 5.5 | 1.7 | 0.2 | 0.6 | |
| 37 | -1.6 | -191 | -189 | 58 | 158 | -51 | -8.6 | |
| – | – | 12 | – | – | – | – | – | |
| -0.1 | 0.0 | -0.2 | 2.0 | 0.8 | -0.1 | -0.2 | -0.2 | |
| 12 | 12 | 12 | 0.0 | 0.0 | -13 | 0.0 | – | |
| 2.0 | 0.2 | 349 | 171 | 1.1 | 45 | 45 | 126 | |
| 22 | 54 | 91 | -105 | -46 | 97 | -71 | 19 | |
| -20 | 54 | -68 | -88 | -111 | -109 | -65 | -99 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.